CLINICAL_TRIALS
research
· 2025-08-05
Clinical Trial Update: Does Abnormal Insulin Action in the Brain Underlie Cognitive and Metabolic Dysfunction in Schizophrenia [NA]
Summary
A clinical trial is investigating whether abnormal insulin action in the brain contributes to cognitive and metabolic dysfunction in schizophrenia; the study is…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Centre for Addiction and Mental Health | Conditions: Schizophrenia, Healthy | NA | Status: RECRUITING